Physician profile
Lance T Taylor
NPI 1568501583
$1,384.06
in general payments reported to CMS, 2019-2025
13 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.70 · 2020: $14.44 · 2021: $43.17 · 2022: $244 · 2023: $265 · 2024: $345 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Education: $46.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.45 |
| Education | $46.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $607.52 | 2021-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $319.39 | 2022-2025 | Stelara, Tremfya, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.03 | 2019-2025 | Xifaxan |
| Celgene Corporation | $53.38 | 2023-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $42.92 | 2025 | Voquezna |
| Madrigal Pharmaceuticals | $35.44 | 2025 | Rezdiffra |
| Olympus America INC. | $32.80 | 2024 | Endoclot Sis, Single Use Repositionable Clip |
| Pfizer INC. | $30.40 | 2024 | |
| Erbe USA INC | $24.30 | 2021 | |
| Merit Medical Systems INC | $24.14 | 2025 | Esophyx |
| Ardelyx, INC. | $16.50 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Daiichi Sankyo INC. | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.